Cumberland Pharmaceuticals (CPIX) Reports Q4 Loss of $0.05

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q4 EPS of ($0.05), versus $0.01 reported last year. Revenue for the quarter came in at $9 million, versus $7.89 million reported last year.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
• Methanex to idle Trinidad Titan plant after gas contract talks fail
• After-Hours Stock Movers: AVAV, PRAX, VSH, CNXC, SHAZ